Acadian Asset Management LLC Takes Position in Glaukos Corporation (NYSE:GKOS)

Acadian Asset Management LLC acquired a new position in shares of Glaukos Corporation (NYSE:GKOS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,720 shares of the medical instruments supplier’s stock, valued at approximately $651,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in GKOS. Great West Life Assurance Co. Can purchased a new position in shares of Glaukos Corporation during the first quarter worth about $102,000. Prudential Financial Inc. purchased a new position in shares of Glaukos Corporation during the first quarter worth about $204,000. State Board of Administration of Florida Retirement System boosted its position in shares of Glaukos Corporation by 1.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 7,699 shares of the medical instruments supplier’s stock worth $264,000 after buying an additional 140 shares during the period. Caxton Associates LP purchased a new position in shares of Glaukos Corporation during the first quarter worth about $272,000. Finally, Engineers Gate Manager LP purchased a new position in shares of Glaukos Corporation during the first quarter worth about $372,000. 89.63% of the stock is currently owned by institutional investors and hedge funds.

Glaukos Corporation (NYSE:GKOS) traded up 3.28% during mid-day trading on Friday, hitting $37.50. 267,533 shares of the company’s stock were exchanged. Glaukos Corporation has a 12 month low of $28.26 and a 12 month high of $52.49. The stock’s market cap is $1.29 billion. The stock’s 50 day moving average price is $40.38 and its 200-day moving average price is $43.21.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/08/12/acadian-asset-management-llc-takes-position-in-glaukos-corporation-nysegkos.html.

GKOS has been the topic of a number of recent analyst reports. Piper Jaffray Companies reissued a “buy” rating and issued a $56.00 price objective on shares of Glaukos Corporation in a research note on Thursday, August 3rd. Roth Capital decreased their price objective on shares of Glaukos Corporation from $60.00 to $54.00 and set a “buy” rating on the stock in a research note on Thursday, August 3rd. Zacks Investment Research raised shares of Glaukos Corporation from a “hold” rating to a “buy” rating and set a $46.00 price objective on the stock in a research note on Friday, July 21st. BidaskClub raised shares of Glaukos Corporation from a “hold” rating to a “buy” rating in a research note on Saturday, June 24th. Finally, TheStreet cut shares of Glaukos Corporation from a “c” rating to a “d+” rating in a research note on Wednesday, May 3rd. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rating to the stock. Glaukos Corporation currently has a consensus rating of “Buy” and a consensus price target of $52.33.

Glaukos Corporation Company Profile

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm’s canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream.

Institutional Ownership by Quarter for Glaukos Corporation (NYSE:GKOS)

Receive News & Ratings for Glaukos Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glaukos Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply